Skip to content

Other segment segments

O&P- EAI
$15M
I&D
$0
O&P- Americas
$0
Other
$0
Technology
$0

Similar metrics at other companies

Chemours logo
CCAdvanced Performance Materials — Asset Impairment Charges
$1M-91.7%
Kulicke & Soffa Industries logo
KLICAPS — Amortization expense:
$0
Kulicke & Soffa Industries logo
KLICAPS — Depreciation
$1.18M-10.2%
Entegris logo
ENTGAPS — Total depreciation
$19.9M-27.6%
Entegris logo
ENTGAPS — Goodwill
$316.3M+1.2%
Greif logo
GEFCustomized Polymer Solutions — Impairment of long lived assets
$4.5M+543%

Other financials

Income statement

See full
Revenue$7.2B-6.3%
Gross profit$701.0M+27.7%
Operating income$239.0M+110%
Net income$125.0M-29.4%
EPS (diluted)$0.38-29.6%

Balance sheet

See full
Cash & equivalents$2.6B+41.1%
Total debt$12.8B+5.1%
Total equity$10.0B-17.8%
Total assets$34.0B-3.5%

Cash flow

See full
Operating cash flow-$269.0M+53.5%
CapEx$269.0M-44.3%
Free cash flow-$538.0M+49.3%

Valuation

See full
Market cap$16.99B-8.2%
Enterprise value$27.14B-8.2%
P/S0.6×0.0×

Profitability

See full
Gross margin9.2%-3.3pp
Operating margin-1%
Net margin-2.7%
FCF margin3.1%-1.6pp

Returns & leverage

See full
Return on equity-7.1%
Debt / equity1.3×+0.3×
Current ratio1.5×-0.3×

Where this comes from

Reported directly by LyondellBasell Industries N.V. in its filing.

Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.

The official record: LyondellBasell Industries N.V.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about LyondellBasell Industries N.V.'s aps — impairments.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LyondellBasell Industries N.V.'s APS — impairments?
LyondellBasell Industries N.V. (LYB) reported APS — impairments of $0 in Q1 2026.
What does APS — impairments mean?
This represents non-cash charges recognized when the carrying value of assets in the Advanced Polymer Solutions segment exceeds their recoverable amount. It signals a downward revision in the expected future economic benefits of segment assets.